Cargando…

Ophthalmic Biomarkers for Alzheimer’s Disease: A Review

Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by neuronal loss, extracellular amyloid-β (Aβ) plaques, and intracellular neurofibrillary tau tangles. A diagnosis is currently made from the presenting symptoms, and the only definitive diagnosis can be done post-mort...

Descripción completa

Detalles Bibliográficos
Autores principales:	Majeed, Ayesha, Marwick, Ben, Yu, Haoqing, Fadavi, Hassan, Tavakoli, Mitra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461312/ https://www.ncbi.nlm.nih.gov/pubmed/34566623 http://dx.doi.org/10.3389/fnagi.2021.720167

Ejemplares similares

Neurodegeneration of the cornea and retina in patients with type 1 diabetes without clinical evidence of diabetic retinopathy
por: Carmichael, Josie, et al.
Publicado: (2022)

Biomarkers in Alzheimer’s Disease
por: Riverol, Mario, et al.
Publicado: (2011)

Electrophysiological Biomarkers of Epileptogenicity in Alzheimer’s Disease
por: Yu, Tingting, et al.
Publicado: (2021)

The landscape of global research on diabetic neuropathy
por: Tavakoli, Mitra, et al.
Publicado: (2023)

Microsaccade Characteristics in Neurological and Ophthalmic Disease
por: Alexander, Robert G., et al.
Publicado: (2018)

An atlas on biomarkers for Alzheimer's disease
por: Martínez-Rivera, Marta
Publicado: (2013)

The Eye As a Biomarker for Alzheimer's Disease
por: Lim, Jeremiah K. H., et al.
Publicado: (2016)

Network-Based Biomarkers in Alzheimer’s Disease: Review and Future Directions
por: Gomez-Ramirez, Jaime, et al.
Publicado: (2014)

Advances in Screening, Early Diagnosis and Accurate Staging of Diabetic Neuropathy
por: Carmichael, Josie, et al.
Publicado: (2021)

Editorial: Immunological Mechanisms, Biomarkers and Immunotherapies of Alzheimer's Disease
por: Xin, Jia-yan, et al.
Publicado: (2021)

Editorial: Biomarkers of Alzheimer’s Disease: The Present and the Future
por: Lehmann, Sylvain, et al.
Publicado: (2016)

Alix: A Candidate Serum Biomarker of Alzheimer’s Disease
por: Sun, Yingni, et al.
Publicado: (2021)

Perivascular spaces as a potential biomarker of Alzheimer’s disease
por: Lynch, Miranda, et al.
Publicado: (2022)

Perifovea retinal thickness as an ophthalmic biomarker for mild cognitive impairment and early Alzheimer's disease
por: Tao, Rui, et al.
Publicado: (2019)

Potential biomarkers of Alzheimer’s disease and cerebral small vessel disease
por: Zou, Chun, et al.
Publicado: (2022)

Neuro-ophthalmic Manifestations of Coronavirus Disease 2019 and Its Vaccination: A Narrative Review
por: Feizi, Mohadeseh, et al.
Publicado: (2023)

microRNA-Based Biomarkers and the Diagnosis of Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2015)

Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics
por: Ritter, Aaron, et al.
Publicado: (2015)

Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology
por: Baird, Alison L., et al.
Publicado: (2015)

Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
por: Huynh, Rose Ann, et al.
Publicado: (2017)

Study on Analysis of Peripheral Biomarkers for Alzheimer’s Disease Diagnosis
por: Rani, Palaniswamy, et al.
Publicado: (2017)

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2020)

CSF metabolites associated with biomarkers of Alzheimer’s disease pathology
por: Dong, Ruocheng, et al.
Publicado: (2023)

MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic Biomarkers
por: Wei, Wei, et al.
Publicado: (2020)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

Ophthalmic Manifestations and Genetics of the Polyglutamine Autosomal Dominant Spinocerebellar Ataxias: A Review
por: Park, Jun Young, et al.
Publicado: (2020)

A Systematic Review of Glucose Transport Alterations in Alzheimer's Disease
por: Kyrtata, Natalia, et al.
Publicado: (2021)

Molecular Chaperone Accumulation in Cancer and Decrease in Alzheimer's Disease: The Potential Roles of HSF1
por: Calderwood, Stuart K., et al.
Publicado: (2017)

The potential of the gut microbiome for identifying Alzheimer’s disease diagnostic biomarkers and future therapies
por: Zhan, Yu, et al.
Publicado: (2023)

Circulating microRNAs in Alzheimer’s disease: the search for novel biomarkers
por: Dorval, Véronique, et al.
Publicado: (2013)

In vivo Brainstem Imaging in Alzheimer’s Disease: Potential for Biomarker Development
por: Braun, David J., et al.
Publicado: (2018)

The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease
por: Maestú, Fernando, et al.
Publicado: (2019)

Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer’s Disease
por: Younes, Laurent, et al.
Publicado: (2019)

Predictive Value of Routine Peripheral Blood Biomarkers in Alzheimer’s Disease
por: Dong, Xiaoyu, et al.
Publicado: (2019)

Plasma biomarkers and their correlation in adult children of parents with Alzheimer’s disease
por: Huang, Ling-Chun, et al.
Publicado: (2022)

Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
por: Noor Eddin, Ahmed, et al.
Publicado: (2023)

Innovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF
por: Mitra, Sumonto, et al.
Publicado: (2019)

REPS1 as a Potential Biomarker in Alzheimer’s Disease and Vascular Dementia
por: Luo, Jiefeng, et al.
Publicado: (2022)

Assessment of Alzheimer’s disease-related biomarkers in patients with obstructive sleep apnea: A systematic review and meta-analysis
por: Cui, Wenqi, et al.
Publicado: (2022)

Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics Analysis
por: Yu, Wuhan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_48h2ggcr7pd8uq3h844efs0afn